Frank T. Baumgart
Chief Executive Officer at MR confon GmbH
Frank T. Baumgart active positions
Companies | Position | Start | End |
---|---|---|---|
MR confon GmbH
MR confon GmbH Medical SpecialtiesHealth Technology MR confon GmbH develops and commercializes brain imaging diagnostic products. The firm's products include headphones, earmuffs, audio-control unit, analogue converter and microphone. Its products comprise communication and active-noise-control for functional magnetic resonance imaging. The company was founded in 2001 and is headquartered in Magdeburg, Germany. | Chief Executive Officer | - | - |
Career history of Frank T. Baumgart
Former positions of Frank T. Baumgart
Companies | Position | Start | End |
---|---|---|---|
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Founder | 2009-08-30 | 2011-08-02 |
Statistics
International
Germany | 3 |
Operational
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
MR confon GmbH
MR confon GmbH Medical SpecialtiesHealth Technology MR confon GmbH develops and commercializes brain imaging diagnostic products. The firm's products include headphones, earmuffs, audio-control unit, analogue converter and microphone. Its products comprise communication and active-noise-control for functional magnetic resonance imaging. The company was founded in 2001 and is headquartered in Magdeburg, Germany. | Health Technology |
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Frank T. Baumgart
- Experience